Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 21, 2021 - Issue 2
Submit an article Journal homepage
807
Views
20
CrossRef citations to date
0
Altmetric
Drug Evaluation

Margetuximab for the treatment of HER2-positive metastatic breast cancer

Paolo Tarantinoa Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;b Department of Oncology and Hematology, University of Milan, Milan, ItalyView further author information
,
Stefania Morgantia Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;b Department of Oncology and Hematology, University of Milan, Milan, ItalyView further author information
,
Jacopo Ulianoa Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;b Department of Oncology and Hematology, University of Milan, Milan, ItalyView further author information
,
Federica Giuglianoa Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;b Department of Oncology and Hematology, University of Milan, Milan, ItalyView further author information
,
Edoardo Criminia Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;b Department of Oncology and Hematology, University of Milan, Milan, ItalyView further author information
&
Giuseppe Curiglianoa Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;b Department of Oncology and Hematology, University of Milan, Milan, ItalyCorrespondence[email protected]
View further author information
Pages 127-133 | Received 02 Oct 2020, Accepted 24 Nov 2020, Published online: 14 Dec 2020

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jacopo Uliano, Eleonora Nicolò, Carla Corvaja, Beatrice Taurelli Salimbeni, Dario Trapani & Giuseppe Curigliano. (2022) Combination immunotherapy strategies for triple-negative breast cancer: current progress and barriers within the pharmacological landscape. Expert Review of Clinical Pharmacology 15:12, pages 1399-1413.
Read now

Articles from other publishers (19)

Haiyan Chang, Ting Hu, Jie Hu, Teng Ding, Qiong Wang & Jing Cheng. (2023) Complete response in patient with liver metastasis of HER2-positive breast cancer following therapy with margetuximab: a case report. Anti-Cancer Drugs 34:7, pages 883-887.
Crossref
Ismail Essadi, Zineb Benbrahim, Mohamed Kaakoua, Thibaut Reverdy, Pauline Corbaux & Gilles Freyer. (2023) HER2-Positive Metastatic Breast Cancer: Available Treatments and Current Developments. Cancers 15:6, pages 1738.
Crossref
Federica Giugliano, Ambra Carnevale Schianca, Chiara Corti, Mariia Ivanova, Nadia Bianco, Silvia Dellapasqua, Carmen Criscitiello, Nicola Fusco, Giuseppe Curigliano & Elisabetta Munzone. (2023) Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution. Cancers 15:5, pages 1385.
Crossref
Sacha Zinn, Rodrigo Vazquez-Lombardi, Carsten Zimmermann, Puja Sapra, Lutz Jermutus & Daniel Christ. (2023) Advances in antibody-based therapy in oncology. Nature Cancer 4:2, pages 165-180.
Crossref
Moudi M. Alasmari. (2022) A Review of Margetuximab-Based Therapies in Patients with HER2-Positive Metastatic Breast Cancer. Cancers 15:1, pages 38.
Crossref
Saleh Alrhmoun & Sergey Sennikov. (2022) The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions. Cancers 14:24, pages 6173.
Crossref
Andrea Nicolini, Paola Ferrari & Angelo Carpi. (2022) Immune Checkpoint Inhibitors and Other Immune Therapies in Breast Cancer: A New Paradigm for Prolonged Adjuvant Immunotherapy. Biomedicines 10:10, pages 2511.
Crossref
Shuang Ma & Fei Chen. (2022) Common strategies for effective immunotherapy of gastroesophageal cancers using immune checkpoint inhibitors. Pathology - Research and Practice 238, pages 154110.
Crossref
Gábor Rubovszky, Judit Kocsis, Katalin Boér, Nataliya Chilingirova, Magdolna Dank, Zsuzsanna Kahán, Dilyara Kaidarova, Erika Kövér, Bibiana Vertáková Krakovská, Károly Máhr, Bela Mriňáková, Béla Pikó, Ivana Božović-Spasojević & Zsolt Horváth. (2022) Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer. Pathology and Oncology Research 28.
Crossref
Shun‐Yu Wu, Fu‐Gen Wu & Xiaoyuan Chen. (2022) Antibody‐Incorporated Nanomedicines for Cancer Therapy. Advanced Materials 34:24, pages 2109210.
Crossref
Konstantinos Venetis, Edoardo Crimini, Elham Sajjadi, Chiara Corti, Elena Guerini-Rocco, Giuseppe Viale, Giuseppe Curigliano, Carmen Criscitiello & Nicola Fusco. (2022) HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer. Frontiers in Molecular Biosciences 9.
Crossref
Carrie S. Wynn & Shou-Ching Tang. (2022) Anti-HER2 therapy in metastatic breast cancer: many choices and future directions. Cancer and Metastasis Reviews 41:1, pages 193-209.
Crossref
Kun Zhou, HaoFei Hong, Han Lin, Liang Gong, Dan Li, Jie Shi, Zhifang Zhou, Fei Xu & Zhimeng Wu. (2021) Chemical Synthesis of Antibody–Hapten Conjugates Capable of Recruiting the Endogenous Antibody to Magnify the Fc Effector Immunity of Antibody for Cancer Immunotherapy. Journal of Medicinal Chemistry 65:1, pages 323-332.
Crossref
Xiaojing Chang, Xiaohui Ge, Yufeng Zhang & Xiaoying Xue. (2022) The current management and biomarkers of immunotherapy in advanced gastric cancer. Medicine 101:21, pages e29304.
Crossref
Kuba Retecki, Milena Seweryn, Agnieszka Graczyk-Jarzynka & Malgorzata Bajor. (2021) The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance. Cancers 13:23, pages 6012.
Crossref
Beatriz Henriques, Fernando Mendes & Diana Martins. (2021) Immunotherapy in Breast Cancer: When, How, and What Challenges?. Biomedicines 9:11, pages 1687.
Crossref
Anna Burguin, Caroline Diorio & Francine Durocher. (2021) Breast Cancer Treatments: Updates and New Challenges. Journal of Personalized Medicine 11:8, pages 808.
Crossref
Alejandro Español, Agustina Salem, Yamila Sanchez & María Elena Sales. (2021) Breast cancer: Muscarinic receptors as new targets for tumor therapy. World Journal of Clinical Oncology 12:6, pages 404-428.
Crossref
Alejandro Garcia-Alvarez, Andri Papakonstantinou & Mafalda Oliveira. (2021) Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies. Cancers 13:12, pages 2927.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.